Artal International S.C.A. has an estimated net worth of $10.6 Billion. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Seer, Inc., Scholar Rock Holding Corp, Generation Bio Co., LEXICON PHARMACEUTICALS, INC., Blue Buffalo Pet Products, Inc., SQZ Biotechnologies Co, Ceres, Inc., WW INTERNATIONAL, INC., GLYCOMIMETICS INC, Furiex Pharmaceuticals, Inc., CAVA GROUP, INC., and MEMORY PHARMACEUTICALS CORP.

2018 was Artal International S.C.A.'s most active year for acquiring shares with 23 total transactions. Artal International S.C.A.'s most active month to acquire stocks was the month of May. 2012 was Artal International S.C.A.'s most active year for disposing of shares, totalling 9 transactions. Artal International S.C.A.'s most active month to dispose stocks was the month of January. 2014 saw Artal International S.C.A. paying a total of $169,545,087.65 for 153,947,942 shares, this is the most they've acquired in one year. In 2018 Artal International S.C.A. cashed out on 107,641,431 shares for a total of $4,525,755,000.00, their largest year based on trade value.